JP Morgan Chase’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $157M | Buy |
|
|||||
|
2022
Q2 | $13M | Buy |
|
|||||
|
2022
Q1 | $6.42M | Buy |
|
|||||
|
2021
Q4 | $4.99M | Buy |
|
|||||
|
2021
Q3 | $1.34M | Sell |
|
|||||
|
2021
Q2 | $2.03M | Sell |
|
|||||
|
2021
Q1 | $30.5M | Buy |
|
|||||
|
2020
Q4 | $30.5M | Buy |
|
|||||
|
2020
Q3 | $35.4M | Sell |
|
|||||
|
2020
Q2 | $46.8M | Buy |
|
|||||
|
2020
Q1 | $23.5M | Buy |
|
|||||
|
2019
Q4 | $34.6M | Buy |
|
|||||
|
2019
Q3 | $20.9M | Buy |
|
|||||
|
2019
Q2 | $21.6M | Buy |
|
|||||
|
2019
Q1 | $20.2M | Buy |
|
|||||
|
2018
Q4 | $15.2M | Buy |
|
|||||
|
2018
Q3 | $13.8M | Buy |
|
|||||
|
2018
Q2 | $14.2M | Buy |
|
|||||
|
2018
Q1 | $5.39M | Sell |
|
|||||
|
2017
Q4 | $8.81M | Sell |
|
|||||
|
2017
Q3 | $6.86M | Sell |
|
|||||
|
2017
Q2 | $6.45M | Buy |
|
|||||
|
2017
Q1 | $8.26M | Buy |
|
|||||
|
2016
Q4 | $2.54M | Sell |
|
|||||
|
2016
Q3 | $4.27M | Buy |
|
|||||
|
2016
Q2 | $2.94M | Sell |
|
|||||
|
2016
Q1 | $2.95M | Sell |
|
|||||
|
2015
Q4 | $6.06M | Sell |
|
|||||
|
2015
Q3 | $9.01M | Buy |
|